 |
 |
          |
|
Welcome to Viralytics Viralytics is a leading anti-cancer biotechnology company. Viralytics has acquired, by licence, an anti-cancer virotherapy technology using the naturally occurring Coxsackievirus and Echovirus. With the acquisition; Viralytics’s focus is now a leading anti-cancer biotech with a worldwide outlook. Viralytics adds value to its projects and investments through its strong business skills, its expertise in project and IP management and its strong experience in business development. A strong management team, complemented by an experienced Board of Directors manages and controls this process. Viralytics link to Viriathus research report Today Tonight - Hope for cancer sufferers Please see au.todaytonight.yahoo.com for more information. |
|
|
|
||||||||||||||
   
|
||||||||||||||||||||
